Kidney Injury in Acute Coronary Syndromes: More Than a Canary in the Cardiovascular Coal Mine?
作者信息
Piana Robert N, Sullivan Alexander E
机构信息
Division of Cardiology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Division of Cardiology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
出版信息
JACC Cardiovasc Interv. 2023 Jan 23;16(2):206-208. doi: 10.1016/j.jcin.2022.10.052. Epub 2022 Dec 28.
Abstract
摘要
相似文献
1
Kidney Injury in Acute Coronary Syndromes: More Than a Canary in the Cardiovascular Coal Mine?急性冠状动脉综合征中的肾损伤：不仅仅是心血管煤矿里的金丝雀？
JACC Cardiovasc Interv. 2023 Jan 23;16(2):206-208. doi: 10.1016/j.jcin.2022.10.052. Epub 2022 Dec 28.
2
Procalcitonin as an Early Predictor of Contrast-Induced Acute Kidney Injury in Patients With Acute Coronary Syndromes Who Underwent Percutaneous Coronary Intervention.降钙素原作为接受经皮冠状动脉介入治疗的急性冠状动脉综合征患者造影剂诱导的急性肾损伤的早期预测指标。
Angiology. 2015 Nov;66(10):957-63. doi: 10.1177/0003319715572218. Epub 2015 Feb 16.
3
Acute kidney injury after percutaneous coronary intervention: Rationale of the AKI-MATRIX (acute kidney injury-minimizing adverse hemorrhagic events by TRansradial access site and systemic implementation of angioX) sub-study.经皮冠状动脉介入治疗后急性肾损伤：AKI-MATRIX（通过桡动脉穿刺部位及血管造影X系统全面应用减少急性肾损伤不良出血事件）子研究的原理
Catheter Cardiovasc Interv. 2015 Nov;86(5):950-7. doi: 10.1002/ccd.25932. Epub 2015 Apr 9.
4
Relationship between inflammation and benefits of early high-dose rosuvastatin on contrast-induced nephropathy in patients with acute coronary syndrome: the pathophysiological link in the PRATO-ACS study (Protective Effect of Rosuvastatin and Antiplatelet Therapy on Contrast-Induced Nephropathy and Myocardial Damage in Patients With Acute Coronary Syndrome Undergoing Coronary Intervention).炎症与早期大剂量瑞舒伐他汀对急性冠脉综合征患者对比剂肾病获益的关系：PRATO-ACS 研究中的病理生理学联系（瑞舒伐他汀和抗血小板治疗对接受经皮冠状动脉介入治疗的急性冠脉综合征患者对比剂肾病和心肌损伤的保护作用）。
JACC Cardiovasc Interv. 2014 Dec;7(12):1421-9. doi: 10.1016/j.jcin.2014.06.023.
5
Impact of Serum Albumin Levels on Contrast-Induced Acute Kidney Injury in Patients With Acute Coronary Syndromes Treated With Percutaneous Coronary Intervention.血清白蛋白水平对接受经皮冠状动脉介入治疗的急性冠状动脉综合征患者造影剂诱导的急性肾损伤的影响。
Angiology. 2015 Sep;66(8):732-7. doi: 10.1177/0003319714551979. Epub 2014 Sep 26.
6
[Acute coronary syndromes with ST-segment elevation and anomalous connections of the coronary arteries].[伴有ST段抬高的急性冠状动脉综合征及冠状动脉异常连接]
Ann Cardiol Angeiol (Paris). 2015 Dec;64(6):453-9. doi: 10.1016/j.ancard.2015.09.051. Epub 2015 Oct 23.
7
The management of acute coronary syndromes in patients with chronic kidney disease.慢性肾脏病患者急性冠状动脉综合征的管理
Adv Chronic Kidney Dis. 2014 Nov;21(6):472-9. doi: 10.1053/j.ackd.2014.08.005. Epub 2014 Oct 24.
8
Treatment disparities in acute coronary syndromes, heart failure, and kidney disease.急性冠状动脉综合征、心力衰竭和肾脏疾病的治疗差异。
Contrib Nephrol. 2011;171:68-73. doi: 10.1159/000327230. Epub 2011 May 23.
9
Is ACS in Young Patients a "Canary in the Coal Mine" for Familial Hypercholesterolemia?年轻患者的急性冠状动脉综合征是家族性高胆固醇血症的“煤矿中的金丝雀”吗？
J Am Coll Cardiol. 2017 Oct 3;70(14):1741-1743. doi: 10.1016/j.jacc.2017.08.019.
10
Therapeutic management and outcome of nonagenarians versus octogenarians admitted to an intensive care unit for acute coronary syndromes.对因急性冠脉综合征入住重症监护病房的 90 岁以上与 80 岁以上患者的治疗管理和预后评估。
Arch Cardiovasc Dis. 2020 Dec;113(12):780-790. doi: 10.1016/j.acvd.2020.05.020. Epub 2020 Oct 5.
本文引用的文献
1
Transient vs In-Hospital Persistent Acute Kidney Injury in Patients With Acute Coronary Syndrome.急性冠状动脉综合征患者的短暂性与院内持续性急性肾损伤
JACC Cardiovasc Interv. 2023 Jan 23;16(2):193-205. doi: 10.1016/j.jcin.2022.10.009. Epub 2022 Dec 28.
2
A contemporary simple risk score for prediction of contrast-associated acute kidney injury after percutaneous coronary intervention: derivation and validation from an observational registry.当代经皮冠状动脉介入治疗后对比剂相关急性肾损伤的简单风险评分：来自观察性注册研究的推导和验证。
Lancet. 2021 Nov 27;398(10315):1974-1983. doi: 10.1016/S0140-6736(21)02326-6. Epub 2021 Nov 15.
3
Treatment patterns and clinical outcomes among patients <65 years with a worsening heart failure event.年龄<65 岁的心力衰竭恶化事件患者的治疗模式和临床结局。
Eur J Heart Fail. 2021 Aug;23(8):1334-1342. doi: 10.1002/ejhf.2252. Epub 2021 Jun 17.
4
Cardiovascular Consequences of Acute Kidney Injury.急性肾损伤的心血管后果
N Engl J Med. 2020 Jun 4;382(23):2238-2247. doi: 10.1056/NEJMra1916393.
5
Persistent Renal Dysfunction in Patients Undergoing Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction.急性心肌梗死后行直接经皮冠状动脉介入治疗患者的持续性肾功能障碍。
J Am Heart Assoc. 2019 Dec 3;8(23):e014096. doi: 10.1161/JAHA.119.014096. Epub 2019 Nov 26.
6
Relationship Between Operator Volume and Long-Term Outcomes After Percutaneous Coronary Intervention.术者手术量与经皮冠状动脉介入治疗后长期结局的关系。
Circulation. 2019 Jan 22;139(4):458-472. doi: 10.1161/CIRCULATIONAHA.117.033325.
7
Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trial.经皮冠状动脉介入治疗的急性冠状动脉综合征患者中桡动脉入路与股动脉入路和比伐卢定与普通肝素的比较（MATRIX）：一项多中心、随机对照试验的最终 1 年结果。
Lancet. 2018 Sep 8;392(10150):835-848. doi: 10.1016/S0140-6736(18)31714-8. Epub 2018 Aug 25.
8
Acute Kidney Injury After Radial or Femoral Access for Invasive Acute Coronary Syndrome Management: AKI-MATRIX.经桡动脉或股动脉途径进行有创急性冠状动脉综合征治疗后的急性肾损伤：AKI-MATRIX研究。
J Am Coll Cardiol. 2017 May 11. doi: 10.1016/j.jacc.2017.02.070.
9
Impact of Contrast-Induced Acute Kidney Injury After Percutaneous Coronary Intervention on Short- and Long-Term Outcomes: Pooled Analysis From the HORIZONS-AMI and ACUITY Trials.经皮冠状动脉介入治疗后对比剂诱导的急性肾损伤对短期和长期预后的影响：来自HORIZONS-AMI和ACUITY试验的汇总分析
Circ Cardiovasc Interv. 2015 Aug;8(8):e002475. doi: 10.1161/CIRCINTERVENTIONS.114.002475.
10
Contrast-induced acute kidney injury after primary percutaneous coronary intervention: results from the HORIZONS-AMI substudy.初次经皮冠状动脉介入治疗后对比剂诱导的急性肾损伤：HORIZONS-AMI 子研究结果。
Eur Heart J. 2014 Jun 14;35(23):1533-40. doi: 10.1093/eurheartj/ehu063. Epub 2014 Mar 6.
Zotero 插件